KAS
ONC

Kestra Advisory Services’s BeOne Medicines Ltd ONC Stock Holding History

Kestra Advisory Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
1,150
+190
+20% +$56K ﹤0.01% 2677
2026
Q1 		$285K Sell
960
-170
-15% -$55K ﹤0.01% 2678
2025
Q4 		$343K Sell
1,130
-45
-4% -$14.7K ﹤0.01% 2434
2025
Q3 		$400K Sell
1,175
-211
-15% -$64.1K ﹤0.01% 2214
2025
Q2 		$336K Buy
1,386
+27
+2% +$6.62K ﹤0.01% 2266
2025
Q1 		$370K Sell
1,359
-244
-15% -$57K ﹤0.01% 2024
2024
Q4 		$296K Buy
1,603
+169
+12% +$34.5K ﹤0.01% 2227
2024
Q3 		$322K Sell
1,434
-121
-8% -$21.8K ﹤0.01% 2045
2024
Q2 		$222K Sell
1,555
-16
-1% -$2.47K ﹤0.01% 2330
2024
Q1 		$246K Buy
1,571
+110
+8% +$17.7K ﹤0.01% 2139
2023
Q4 		$264K Sell
1,461
-2
-0.1% -$362 ﹤0.01% 1930
2023
Q3 		$263K Buy
1,463
+221
+18% +$43.7K ﹤0.01% 1754
2023
Q2 		$221K Sell
1,242
-299
-19% -$68.9K ﹤0.01% 1840
2023
Q1 		$332K Sell
1,541
-1,092
-41% -$262K ﹤0.01% 1504
2022
Q4 		$579K Buy
2,633
+303
+13% +$55.6K 0.01% 1318
2022
Q3 		$314K Buy
2,330
+37
+2% +$6.35K ﹤0.01% 1570
2022
Q2 		$371K Buy
2,293
+50
+2% +$7.81K ﹤0.01% 1495
2022
Q1 		$423K Buy
2,243
+222
+11% +$47.2K ﹤0.01% 1386
2021
Q4 		$548K Sell
2,021
-84
-4% -$28.4K 0.01% 1273
2021
Q3 		$764K Buy
2,105
+59
+3% +$19.3K 0.01% 1158
2021
Q2 		$702K Buy
2,046
+133
+7% +$44.1K 0.01% 1109
2021
Q1 		$666K Buy
1,913
+689
+56% +$228K 0.01% 1052
2020
Q4 		$312K Buy
1,224
+1,208
+7,550% +$333K ﹤0.01% 1453
2020
Q3 		$358K Buy
+16
New +$3.76K 0.01% 1025

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kestra Advisory Services's ONC Position: Q2 2026 in Review

Kestra Advisory Services increased its BeOne Medicines Ltd (ONC) stake by 20% in Q2 2026, buying an estimated $56K and bringing the position to 1,150 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

Kestra Advisory Services first reported a position in ONC in Q3 2020 and has held it in 24 quarters since. The position peaked at $764K in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Kestra Advisory Services held 1,150 shares of BeOne Medicines Ltd worth $328K as of Q2 2026.
  • Kestra Advisory Services bought 190 BeOne Medicines Ltd shares in Q2 2026, an estimated $56K.
  • BeOne Medicines Ltd made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2677 holding.
  • Kestra Advisory Services first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's BeOne Medicines Ltd position peaked at $764K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.